Navigation Links
Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows
Date:10/31/2012

Clinical hypnosis can effectively reduce hot flashes and associated symptoms among postmenopausal women, according to a new study conducted by researchers at Baylor University's Mind-Body Medicine Research Laboratory.

Hypnotic relaxation therapy reduced hot flashes by as much as 80 percent, and the findings also showed participants experienced improved quality of life and a lessening of anxiety and depression.

The mind-body therapy study of 187 women over a five-week period measured both physical symptoms of hot flashes and women's self-reporting of flashes. The women received weekly sessions of hypnosis by clinically trained therapists, and they also practiced self-hypnosis using audio recordings and such visualizations as a snowy path or a cool mountain creek, according to the study, published online in Menopause: The Journal of The North American Menopause Society and funded by the National Center for Complementary and Alternative Medicine of the National Institutes of Health.

"This is the first study in which we compared both self-reporting and physiological monitoring not just a change in tolerance or ability to cope, but the hot flashes themselves decreased," said Gary Elkins, Ph.D., professor of psychology and neuroscience in Baylor's College of Arts & Sciences and director of the Mind-Body Medicine Research Laboratory.

By the fourth session, hot flashes had decreased about 70 percent, and at a three-month follow-up, the decrease averaged 80 percent, he said. "Some women reported having nearly complete elimination of hot flashes."

To be clinically significant, the decrease must be 50 percent or more, he said. Besides decreasing in frequency, the hot flashes also became milder.

"For women who want to be involved in their own therapy, this is very appealing," Elkins said. "It also has the advantages of cost savings and few or no side effects. Over the long term, the intervention has the potential to reduce health care costs and provide a safe and effective choice for women during menopause."

Other treatment options are hormones estrogen or progestin which are most effective with a range of 90 to 100 percent reduction in hot flashes, but associated with increased risk of breast cancer or heart disease; antidepressants, with a decrease in the range of 45 to 60 percent but with possible side effects such as dry mouth and decreased interest in sex; and herbal remedies, generally found to be of little more benefit than a placebo, Elkins said.

During the study, women wore skin monitors with electrodes. They pushed a response button when they experienced a flash, and the monitor also recorded physiological changes such as temperature.

"This is one of the largest studies for menopausal intervention that has been done, and certainly for mind-body intervention," Elkins said.

"Our next steps are to determine if the intervention can be provided by audio and video recordings as well as the long-term cost benefits," he said. "If it can be provided by audio recording, we could achieve a wide usage and potentially help millions of women. Studies also need to be done to see whether this could benefit the immune system and ward off disease."

Research findings mirrored results of an earlier Baylor study using hypnosis to reduce hot flashes in breast cancer survivors.


'/>"/>

Contact: Terry Goodrich
terry_goodrich@baylor.edu
254-710-3321
Baylor University
Source:Eurekalert

Related biology news :

1. BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
2. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
3. New Market Forecasts Available for Critical Global Biotechnology Testing and Screening Markets: Molecular Diagnostics, Hematology, Clinical Chemistry and Nucleic Acid Testing
4. BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research
5. International Life Sciences Conferences Address Advancements in High-Content Analysis, Sample Preparation, Clinical Trial Supply and Protein and Antibody Engineering
6. MedNet Solutions Announces Latest Enhancements To Its iMedNet EDC eClinical Solution
7. Therapies for spinal cord injury: On the cutting edge of clinical translation
8. University of Tennessee Space Institute researchers make clinical trials a virtual reality
9. As TB grows more difficult to control, vaccine candidate to prevent disease enters clinical testing
10. Clinical trial for rabies monoclonal antibody
11. Published clinical trial demonstrates efficacy of Sea-Band® for migraine-related nausea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/23/2017)... 23, 2017 The report "Gesture Recognition and Touchless Sensing ... Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is expected ... 29.63% between 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... NY (PRWEB) , ... October 12, 2017 , ... ... of Sciences today announced the three Winners and six Finalists of the 2017 ... given annually by the Blavatnik Family Foundation and administered by the New York ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first-ever genomics analysis platform specifically designed for life science researchers to analyze ... pioneering researcher Rosalind Franklin, who made a major contribution to the discovery ...
(Date:10/11/2017)... ... 2017 , ... Proscia Inc ., a data solutions ... “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing ... how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
Breaking Biology Technology: